WallachBeth Capital announced the completion of an underwritten public offering of 1,100,000 units for ABVC BioPharma, Inc. (NASDAQ: Common stock – ABVC) at an offering price of $6.25 per unit for total gross proceeds of $6.875 million, before deducting underwriting discounts and commissions and other estimated offering expenses and before any exercise of the underwriters’ overallotment option.